Cerecin: A research and clinical trials success story

Global pharmaceutical company Cerecin, which develops therapeutics for neurological disorders, is undertaking clinical trials and expanding its research capabilities in Melbourne, Australia. Charles Stacey, Cerecin’s President and CEO, explains why it has chosen Australia to expand its global footprint. Benefits include its diverse population mix, R&D incentives and human capital.